179 related articles for article (PubMed ID: 25159323)
1. Arginine is preferred to glucagon for stimulation testing of β-cell function.
Robertson RP; Raymond RH; Lee DS; Calle RA; Ghosh A; Savage PJ; Shankar SS; Vassileva MT; Weir GC; Fryburg DA;
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E720-7. PubMed ID: 25159323
[TBL] [Abstract][Full Text] [Related]
2. A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
Fritsche A; Stefan N; Hardt E; Schützenauer S; Häring H; Stumvoll M
Eur J Clin Invest; 2000 May; 30(5):411-8. PubMed ID: 10809901
[TBL] [Abstract][Full Text] [Related]
3. Comparison of an oral mixed meal plus arginine and intravenous glucose, GLP-1 plus arginine to unmask residual islet function in longstanding type 1 diabetes.
Uitbeijerse BS; Nijhoff MF; de Koning EJP
Am J Physiol Endocrinol Metab; 2024 May; 326(5):E673-E680. PubMed ID: 38446636
[TBL] [Abstract][Full Text] [Related]
4. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
[TBL] [Abstract][Full Text] [Related]
5. Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve.
Sjostrand M; Carlson K; Arnqvist HJ; Gudbjörnsdottir S; Landin-Olsson M; Lindmark S; Nyström L; Svensson MK; Eriksson JW; Bolinder J
J Intern Med; 2014 Jan; 275(1):39-48. PubMed ID: 24482829
[TBL] [Abstract][Full Text] [Related]
6. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
[TBL] [Abstract][Full Text] [Related]
7. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
[TBL] [Abstract][Full Text] [Related]
9. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
[TBL] [Abstract][Full Text] [Related]
11. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
Kruszynska YT; Goulas S; Wollen N; McIntyre N
J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
[TBL] [Abstract][Full Text] [Related]
12. Arginine Metabolism Is Altered in Adults with A-β + Ketosis-Prone Diabetes.
Mulukutla SN; Hsu JW; Gaba R; Bohren KM; Guthikonda A; Iyer D; Ajami NJ; Petrosino JF; Hampe CS; Ram N; Jahoor F; Balasubramanyam A
J Nutr; 2018 Feb; 148(2):185-193. PubMed ID: 29490093
[TBL] [Abstract][Full Text] [Related]
13. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.
RISE Consortium
Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506
[TBL] [Abstract][Full Text] [Related]
14. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
15. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
[TBL] [Abstract][Full Text] [Related]
16. Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans.
Carpentier A; Giacca A; Lewis GF
Diabetologia; 2001 Nov; 44(11):1989-97. PubMed ID: 11719829
[TBL] [Abstract][Full Text] [Related]
17. Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
Rickels MR; Mueller R; Markmann JF; Naji A
J Clin Endocrinol Metab; 2009 Jan; 94(1):181-9. PubMed ID: 18957498
[TBL] [Abstract][Full Text] [Related]
18. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M
Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
[TBL] [Abstract][Full Text] [Related]
19. Early-phase insulin secretion during mixed-meal tolerance testing predicts β-cell function and secretory capacity in cystic fibrosis.
Sheikh S; Stefanovski D; Kilberg MJ; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
Front Endocrinol (Lausanne); 2024; 15():1340346. PubMed ID: 38444582
[TBL] [Abstract][Full Text] [Related]
20. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ; Prigeon RL; D'Alessio DA
Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
